Calliditas: Orphan drug designation granted by the FDA
Research Note
2019-02-05
12:31
Calliditas announced earlier today that FDA has granted orphan drug designation for the treatment of Autoimmune hepatitis. The news was expected and provide Calliditas with the usual Orphan drug-related advantages.
MS
Mathias Spinnars
Disclosures and disclaimers